Search Results

An Uncommon Approach Through a Profunda Collateral

Utilizing a transcollateral approach to revascularize a superficial femoral artery chronic total occlusion.

By Michael J. Pompliano, BS, and George L. Adams, MD, MHS, FACC

Low-Profile CLI Devices

The latest innovations in outflow treatment devices are expanding options for a growing CLI patient population.

By George L. Adams, MD, MHS, FACC, and Michael J. Pompliano, BS

Retrograde Approach to Crossing CTOs in the Setting of CLI

An exotic and technically challenging approach that can save lives and limbs.

By Michael J. Pompliano, BS, and George L. Adams, MD, MHS, FACC

Improving Carotid Revascularization Outcomes Through Collaboration

By Sumaira Macdonald, MBChB (Comm.), FRCP, FRCR, PhD, and William A. Gray, MD

Chief Medical Editor's Page

VTE Therapy

By Barry T. Katzen, MD

CLI: Where We Stand

By Jihad A. Mustapha, MD

What Is Your Preferred EVAR Device and Why?

By Michael J. Singh, MD, FACS, RPVI; Sharif Ellozy, MD; Mark K. Eskandari, MD, FACS; Ross Milner, MD; Ronald M. Fairman, MD; and Peter R. Nelson, MD, MS

Editor's Access and Closure Challenge: How Would You Do It?

Endovascular Today's Guest Chief Medical Editor, Dr. John H. Rundback, presented four challenging PAD cases to a panel of interventional experts and asked them to answer a series of questions on their preferred methods for assessment, access, and treatment.

With John H. Rundback, MD, FSVM, FAHA, FSIR; Mark Fleming, MD, FACS, RPVI; Paramjit Chopra, MD; and J. Michael Bacharach, MD, FACC, FSCAI, MPH

C-TRACT Trial: Coming Together to Tackle Chronic DVT

Why C-TRACT is needed, its study design, and how current endovascular practitioners can support it.

By Suresh Vedantham, MD

Thoracic Endograft Performance Evaluations

Insights shared at the 2007 Cleveland Clinic Stent Summit.

By Robert G. Whirley, PhD; Mike Nilson, BS; Catherine Szyman, MBA; Matthew S. Waninger, PhD; and Roy K. Greenberg, MD

Playing Offense in Postthrombotic Syndrome: The C-TRACT Trial Opportunity

Why a randomized controlled trial is important to evaluate iliac vein stenting in PTS and how the C-TRACT trial can help resolve unanswered questions.

By Suresh Vedantham, MD